Mode
Text Size
Log in / Sign up

Meta-analysis shows rTMS associated with reduced VAS and SF-MPQ scores in neuropathic painMagnetic brain pulses ease nerve pain for many patients today

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the significant reduction in VAS and SF-MPQ scores associated with rTMS in neuropathic pain.

This meta-analysis investigated the impact of repetitive transcranial magnetic stimulation (rTMS) using various parameters, such as stimulation duration, intensity, pulse number, frequency, and target region, on patients with neuropathic pain. The authors synthesized data regarding several pain-related outcomes, including VAS, SF-MPQ, and NRS scores.

The analysis demonstrated significant improvements in certain pain metrics. Specifically, rTMS was associated with a reduction in VAS scores (SMD = -0.86, 95% CI: -1.51 to -0.22, P = 0.01) and a reduction in SF-MPQ scores (MD = -5.79, 95% CI: -6.36 to -5.22, P < 0.001). However, the meta-analysis did not detect a significant effect on NRS scores (MD = -0.41, 95% CI: -1.07 to 0.25, P = 0.22).

Data regarding the specific study population size, follow-up duration, and safety profiles, including adverse events or discontinuations, were not reported in the provided data. Because the results varied across different pain measurement scales, clinicians should interpret the association between rTMS and pain reduction with caution.

Imagine waking up with a burning sensation in your feet that never goes away. You have tried medicine, therapy, and even surgery. Nothing seems to stop the pain. You feel stuck in a cycle of discomfort that ruins your sleep and your mood.

This is the reality for millions of people with neuropathic pain. It is not just a dull ache. It is a sharp, electric, or burning pain that feels different from a normal injury.

The Problem With Current Treatments

Doctors have many tools to treat this condition. They prescribe antidepressants, anti-seizure drugs, and painkillers. But these medicines often cause side effects like dizziness, nausea, or confusion. Some patients simply do not get enough relief from them.

Many patients feel like they have run out of options. They need a new way to calm the overactive nerves causing the pain. The current standard of care leaves a large group of people without effective solutions.

A New Way To Calm The Nerves

But here is the twist. Scientists have found a way to use magnets to change how the brain processes pain signals. This method is called transcranial magnetic stimulation. It uses a coil held against the head to send magnetic pulses to specific brain areas.

Think of the brain like a busy factory. Pain signals are like trucks driving through a crowded hallway. Sometimes the trucks get stuck or go the wrong way. The magnets act like a traffic controller. They gently guide the signals back to the correct path.

This process does not involve surgery or strong drugs. It is non-invasive and safe for most people. The magnetic field passes through the skull to reach the brain tissue underneath.

How The Study Was Done

Researchers looked at fourteen different studies to see if this method really works. They combined data from hundreds of patients to get a clear picture. The studies tested different settings for the magnets. They changed how long the pulses lasted and how strong they were.

The team focused on two main ways to measure pain. They used the Visual Analog Scale. This asks patients to mark a line to show their pain level. They also used the Somatic Pain Questionnaire. This asks about how pain affects daily life.

The combined results were very encouraging. Patients who received the magnetic stimulation reported much lower pain levels. The average pain score dropped significantly compared to those who did not receive the treatment.

This improvement was seen across different types of nerve pain. Whether the pain was in the hands or the feet, the treatment helped. The effect was strong enough to be noticed by both the patients and the doctors.

This doesn't mean this treatment is available yet.

The study also looked at different pain scales. Some scales measure pain very precisely. The results showed improvement on the scales that matter most to patients. This means the treatment works in real life, not just in a lab.

If you have nerve pain, this news is important. It suggests there is a new option to discuss with your doctor. You might ask about trying this therapy if other treatments have failed.

It is not a magic cure. But it offers a new tool to add to your pain management plan. Many clinics are already using similar techniques for depression and anxiety. Using them for pain is a logical next step.

The Limits Of The Research

There are some things to keep in mind. The studies included in this review were not all the same size. Some had fewer patients than others. This means the results are strong but not perfect yet.

Also, the treatment settings varied between studies. Some used stronger magnets than others. Finding the perfect setting for every person will take more time.

What Happens Next

More research is needed to make this a standard treatment. Scientists will test different settings to find the best ones for each person. They will also look at long-term results to see if the pain stays away.

If the results hold up, insurance companies might start covering this therapy. It could become a common option in pain clinics around the world. For now, talk to your doctor about whether this is right for you.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
ObjectiveTo evaluate the effects of various transcranial magnetic stimulation (TMS) parameters—including stimulation duration, intensity, pulse number, frequency, and target region—on pain scores in patients with neuropathic pain (NP).MethodsRandomized controlled trials (RCTs) assessing the effects of TMS on NP were identified through searches of PubMed, Embase, Web of Science, and the Cochrane Library. Data were analyzed using Stata 18.0 with a random-effects model. Meta-regression, subgroup, sensitivity, and publication bias analyses were also performed.ResultsA total of 14 studies met the eligibility criteria and were included in the meta-analysis. Overall, the pooled findings showed that rTMS was associated with significant improvements in pain outcomes, as reflected by reductions in VAS scores (SMD = -0.86, 95% CI: -1.51 to -0.22, P = 0.01) and SF-MPQ scores (MD = -5.79, 95% CI: -6.36 to -5.22, P < 0.001) in patients with NP. By contrast, no significant effect was detected for NRS scores (MD = -0.41, 95% CI: -1.07 to 0.25, P = 0.22). Further subgroup analyses suggested that studies characterized by a shorter intervention period (
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.